From July 1, 2022 to December 31, 2022, the company has repurchased 676,994 shares, representing 0.21% for CNY 43.31 million. With this, the company has completed the repurchase of 1,436,614 shares, representing 0.45% for CNY 98.02 million under the buyback announced on February 7, 2022.
Qingdao Haier Biomedical Co.,Ltd
Equities
688139
CNE100003P25
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
38.3 CNY | -3.58% | -0.31% | -5.48% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.48% | 1.67B | |
+9.55% | 222B | |
+14.41% | 196B | |
+24.02% | 148B | |
+33.92% | 114B | |
+4.79% | 65.69B | |
+12.92% | 51.88B | |
+3.16% | 50.02B | |
-4.32% | 38.81B | |
-1.99% | 34.59B |
- Stock Market
- Equities
- 688139 Stock
- News Qingdao Haier Biomedical Co.,Ltd
- Tranche Update on Qingdao Haier Biomedical Co., Ltd's Equity Buyback Plan announced on February 7, 2022.